|
Formation of heterocycles by the Mitsunobu reaction. Stereoselective synthesis of (+)-α-skytanthine
|
journal
|
April 1996 |
|
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics
|
journal
|
February 2003 |
|
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N -myristoyltransferase. Part 1
|
journal
|
July 2001 |
|
A fluorescence-based assay for N-myristoyltransferase activity
|
journal
|
February 2012 |
|
Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors
|
journal
|
July 2019 |
|
N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis
|
journal
|
March 2010 |
|
Protein production by auto-induction in high-density shaking cultures
|
journal
|
May 2005 |
|
Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses
|
journal
|
April 2017 |
|
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System
|
journal
|
August 2019 |
|
Identification of Selective Inhibitors of Plasmodium N-Myristoyltransferase by High-Throughput Screening
|
journal
|
December 2019 |
|
N -Myristoylation as a Drug Target in Malaria: Exploring the Role of N -Myristoyltransferase Substrates in the Inhibitor Mode of Action
|
journal
|
January 2018 |
|
Drug Evolution Concept in Drug Design: 1. Hybridization Method
|
journal
|
December 2004 |
|
Discovery of Plasmodium vivax N -Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding Mode
|
journal
|
March 2012 |
|
Design and Synthesis of Inhibitors of Plasmodium falciparumN -Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery
|
journal
|
September 2012 |
|
Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N -Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)
|
journal
|
March 2014 |
|
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
|
journal
|
October 2008 |
|
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
|
journal
|
April 2010 |
|
Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach
|
journal
|
December 2013 |
|
Global profiling of co- and post-translationally N-myristoylated proteomes in human cells
|
journal
|
September 2014 |
|
High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation
|
journal
|
February 2020 |
|
NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle
|
journal
|
February 2020 |
|
Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
|
journal
|
September 2023 |
|
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus
|
journal
|
May 2018 |
|
Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase
|
journal
|
January 2015 |
|
Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase
|
journal
|
January 2017 |
|
Characterization of N-myristoyltransferase from Plasmodium falciparum
|
journal
|
May 2000 |
|
The Integrated Resource for Reproducibility in Macromolecular Crystallography: Experiences of the first four years
|
journal
|
November 2019 |
|
Protein fatty acid acylation: enzymatic synthesis of an N-myristoylglycyl peptide.
|
journal
|
May 1986 |
|
Human N-Myristoyltransferase Amino-terminal Domain Involved in Targeting the Enzyme to the Ribosomal Subcellular Fraction
|
journal
|
November 1997 |
|
A Second Mammalian N-Myristoyltransferase
|
journal
|
March 1998 |
|
Myristoyl-CoA:Protein N-Myristoyltransferase, an Essential Enzyme and Potential Drug Target in Kinetoplastid Parasites
|
journal
|
February 2003 |
|
Relapses ofPlasmodium vivaxInfection Usually Result from Activation of Heterologous Hypnozoites
|
journal
|
April 2007 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
XDS
|
journal
|
January 2010 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
How good are my data and what is the resolution?
|
journal
|
June 2013 |
|
Immobilized metal-affinity chromatography protein-recovery screening is predictive of crystallographic structure success
|
journal
|
August 2011 |
|
High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease
|
journal
|
August 2011 |
|
Structural genomics of infectious disease drug targets: the SSGCID
|
journal
|
August 2011 |
|
The CCP4 suite: integrative software for macromolecular crystallography
|
journal
|
May 2023 |
|
Acylation of Proteins with Myristic Acid Occurs Cotranslationally
|
journal
|
November 1987 |
|
Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis
|
journal
|
May 2018 |
|
Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression
|
journal
|
December 2017 |
|
The prevention and treatment of Plasmodium vivax malaria
|
journal
|
April 2021 |
|
Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs
|
journal
|
April 2012 |
|
The Seattle Structural Genomics Center for Infectious Disease (SSGCID)
|
journal
|
October 2009 |